Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-08-20 08:20 am Sale | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 252,626 0.330% | -8,629,197 (-97.16%) | View |
| 2024-01-02 5:06 pm Sale | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 8,881,823 12.040% | -5,014,652 (-36.09%) | View |
| 2023-07-10 10:20 am Sale | 13G | Oncology Institute Inc. TOI | FMR LLC | 4,754,083 6.309% | -7,247,899 (-60.39%) | View |
| 2023-04-03 06:00 am Sale | 13G | Oncology Institute Inc. TOI | Agajanian Richy | 3,565,652 4.800% | -554,217 (-13.45%) | View |
| 2023-02-09 12:01 pm Purchase | 13G | Oncology Institute Inc. TOI | FMR LLC | 12,001,982 16.590% | 1,982 (+0.02%) | View |
| 2023-01-10 4:30 pm Sale | 13G | Oncology Institute Inc. TOI | Agajanian Richy | 4,119,869 5.700% | -4,029,255 (-49.44%) | View |
| 2022-11-07 5:02 pm Sale | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 13,896,475 18.900% | -817,440 (-5.56%) | View |
| 2022-09-26 4:15 pm Unchanged | 13D | Oncology Institute Inc. TOI | M33 Growth I L.P. | 13,703,803 18.600% | 0 (Unchanged) | View |
| 2022-09-20 6:54 pm Sale | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 14,713,915 20.000% | -948,879 (-6.06%) | View |
| 2022-07-12 4:05 pm Unchanged | 13D | Oncology Institute Inc. TOI | M33 Growth I L.P. | 13,703,803 18.100% | 0 (Unchanged) | View |
| 2022-07-11 4:01 pm Unchanged | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 15,662,794 21.000% | 0 (Unchanged) | View |
| 2022-02-14 4:23 pm Purchase | 13G | Oncology Institute Inc. TOI | Park West Asset Management LLC | 62,200 0.300% | 62,200 (New Position) | View |
| 2022-02-14 4:01 pm Purchase | 13G | Oncology Institute Inc. TOI | INTEGRATED CORE STRATEGIES (US) LLC | 41,041 0.100% | 41,041 (New Position) | View |
| 2022-02-14 06:22 am Purchase | 13G | Oncology Institute Inc. TOI | CITADEL ADVISORS LLC | 41,011 0.100% | 41,011 (New Position) | View |
| 2022-02-10 4:36 pm Purchase | 13G | Oncology Institute Inc. TOI | DAVIDSON KEMPNER PARTNERS | 318,710 0.430% | 318,710 (New Position) | View |
| 2021-12-10 08:52 am Purchase | 13G | Oncology Institute Inc. TOI | FMR LLC | 12,000,000 12.467% | 12,000,000 (New Position) | View |
| 2021-11-24 8:24 pm Purchase | 13G | Oncology Institute Inc. TOI | Agajanian Richy | 8,149,124 10.930% | 8,149,124 (New Position) | View |
| 2021-11-24 4:15 pm Purchase | 13G | Oncology Institute Inc. TOI | FOG Ventures Investments LLC | 4,634,908 6.200% | 4,634,908 (New Position) | View |
| 2021-11-22 4:41 pm Purchase | 13D | Oncology Institute Inc. TOI | M33 Growth I L.P. | 13,703,803 18.700% | 13,703,803 (New Position) | View |
| 2021-11-22 4:25 pm Purchase | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 15,662,794 21.000% | 15,662,794 (New Position) | View |